ipamorelin / cjc1295 no dac CJC-1295 + Blend Research Vial CJC-1295 (no DAC) & Ipamorelin

Understanding this timeline helps patients maintain motivation and commitment during the initial adaptation period

Clin Chem

This trial was discontinued because the clinical endpoints did not reach statistical significance when comparing ipamorelin to placebo [9]

nIpamorelin is a pentapeptide (5-amino acid) GHRP that selectively binds ghrelin receptors on somatotroph cells to trigger GH release

Whether you're using CJC-1295/Ipamorelin, Tesamorelin, or another peptide blend, understanding how these therapies work will help you feel confident and committed to your care plan

Patients who switched from sermorelin to ipamorelin report fewer side effects like flushing and water retention